{"id":"hexyldecanoic-acid","rwe":[{"pmid":"26572363","year":"2016","title":"Adsorption properties of cross-linked cellulose-epichlorohydrin polymers in aqueous solution.","finding":"","journal":"Carbohydrate polymers","studyType":"Clinical Study"}],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"unknown","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"isocarb 16","offLabel":[],"synonyms":["2-Hexyldecanoic acid","2-n-Hexyldecanoic acid","C16 Guerbet fatty acid","Isocarb 16","hexyldecanoic acid"],"timeline":[],"approvals":[],"brandName":"Isocarb 16","ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Imagine your body's cells are like locks, and Isocarb 16 is a key that fits into one of those locks. When it binds to the lock, it can either turn it on or off, depending on how it's designed. However, since we don't know what lock Isocarb 16 fits into, we can't say exactly how it works or what effects it might have on the body.","oneSentence":"Isocarb 16 is thought to work by interacting with specific biological pathways, but the exact mechanism is unknown.","technicalDetail":"Isocarb 16, or hexyldecanoic acid, is a fatty acid derivative with a hexyl chain. Its mechanism of action is likely to involve interaction with specific receptors or enzymes, but further research is needed to determine the precise molecular details."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3278","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=hexyldecanoic acid","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:53:15.017526","biosimilars":[],"competitors":[],"genericName":"hexyldecanoic acid","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"49M19XFI8B","CHEBI":"CHEBI:135056","UMLSCUI":"C0910084","PUBCHEM_CID":"32912","MESH_SUPPLEMENTAL_RECORD_UI":"C400263"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":1,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[{"date":"2016 Jan 20","pmid":"26572363","title":"Adsorption properties of cross-linked cellulose-epichlorohydrin polymers in aqueous solution.","journal":"Carbohydrate polymers"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"unknown","modality":"Small Molecule","firstApprovalDate":"","aiSummary":"Isocarb 16, also known as hexyldecanoic acid, is a small molecule compound with unknown target and drug class. Its commercial status is unclear, and it has not been approved by the FDA for any indications. As a small molecule, it is likely to work by interacting with specific biological pathways, but the exact mechanism is unknown. Further research is needed to determine its potential therapeutic applications and safety profile. Isocarb 16's development history is also unclear, with no information available on its original developer or current owner.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}